Our firm is about people. That is our motto and that will always be our reality.
We do our best to get to know our clients, understand their situations, and get them the compensation they deserve.
At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.
Without our team, we would’nt be able to provide our clients with anything close to the level of service they receive when they work with us.
The TorHoerman Law Team commits to the sincere belief that those injured by the misconduct of others, especially large corporate profit mongers, deserve justice for their injuries.
Our team is what has made TorHoerman Law a very special place since 2009.
Nevro spinal cord stimulator lawsuit claims center on allegations that certain implanted pain devices may have failed, caused harmful complications, or exposed patients to additional procedures after problems developed.
Spinal stimulator devices may be linked to serious injuries and complications including lead migration, loss of therapeutic benefit, painful stimulation, infection, device malfunction, nerve injury, and revision or explant surgery.
TorHoerman Law is reviewing claims involving injuries linked to spinal stimulator devices.
Nevro manufactures spinal cord stimulation systems used to treat chronic, intractable pain in the trunk or limbs.
Nevro’s primary product lines include the Senza, Senza II, and Senza Omnia platforms, which FDA materials describe as rechargeable spinal cord stimulation systems approved for certain chronic pain indications.
Nevro’s platform is best known for high-frequency spinal cord stimulation, and the company has promoted that technology through clinical trials and FDA approval materials tied to its Senza systems.
Like other implanted pain devices, these systems were developed to reduce severe pain when other treatment options did not provide adequate relief.
Some patients, however, allege that they suffered complications after implantation.
Reported problems in spinal cord stimulator cases have included loss of therapeutic benefit, lead migration, painful or unintended stimulation, infection, charging problems, and the need for revision or explant surgery.
Those allegations can raise serious patient safety concerns when a device allegedly created new medical problems instead of improving pain control.
A defective medical device lawsuit involving a Nevro spinal cord stimulator may focus on whether the implanted system malfunctioned, whether adequate warnings were provided, and whether the device led to additional treatment, surgery, or other harm after implantation.
TorHoerman Law is reviewing claims involving Nevro spinal cord stimulators for patients who experienced serious complications after implantation.
If you or a loved one experienced complications following spinal cord stimulator surgery, you may be eligible to pursue compensation through a Nevro Spinal Cord Stimulator Lawsuit.
Contact TorHoerman Law for a free consultation.
Use the chatbot on this page for a free case review and to find out if you qualify for the Nevro Spinal Cord Stimulator Lawsuit instantly.
Nevro spinal cord stimulator litigation involves claims that certain implanted pain devices malfunctioned, failed to provide consistent therapy, or led to complications that required additional treatment or surgery.
These cases are based on allegations made in lawsuits and claim investigations, not findings of liability.
Spinal cord stimulation devices are used to alter pain signals in patients with difficult-to-treat conditions such as chronic back pain, complex regional pain syndrome, and failed back surgery syndrome.
Nevro’s FDA-approved systems include the Senza, Senza II, and Senza Omnia platforms, which are implanted, rechargeable systems designed to treat chronic pain in the trunk or limbs.
In these cases, the central issue is usually whether a spinal cord stimulator implanted during a pain procedure performed as expected after surgery.
Plaintiffs may allege that the device lost effectiveness, migrated, malfunctioned, caused painful or unintended stimulation, or created new medical problems after implantation.
Some claims focus on inadequate pain relief.
Others focus on whether the device or one of its components allegedly caused further injury, revision surgery, or removal of the system.

Common allegations in Nevro spinal cord stimulator litigation include:
A defective medical device claim involving Nevro turns on specific facts: the model implanted, the patient’s medical history, when symptoms began, and what the follow-up records show.
Those records may include operative notes, imaging, programming history, and documentation of later treatment.
Nevro’s systems are high-frequency spinal cord stimulation devices, not burst stimulation devices.
That distinction matters from a product-identification standpoint, but the legal questions remain similar to those raised in other spinal cord stimulator cases: whether the device functioned properly, whether adequate warnings were given, and whether the implanted system contributed to the patient’s injuries.
Spinal cord stimulator complications can affect both the device’s ability to deliver therapy and the patient’s physical condition after implantation.
Patients have described problems such as worsening pain, inadequate pain relief, lead migration, charging problems, device malfunction, undesired nerve stimulation, burning sensations, and other serious injury reports.
This means some people say their spinal cord stimulators work inconsistently after spinal cord stimulator implantation or stop providing the level of pain relief they expected after surgery.
Others report severe pain, abnormal shocking or burning sensations, or symptoms suggesting irritation of tissue near the spinal cord.
When complications continue, some patients undergo revision procedures or full removal of the device.
That can turn a treatment intended to manage chronic pain into an extended course of follow-up care, added medical expenses, and another spinal cord stimulator surgery.
Reported spinal cord stimulator injuries in this setting may include infection, nerve injury, severe pain, loss of therapy, and the need for explant surgery after the original spinal cord stimulator operation.

Potential injuries and complications may include:
Nevro manufactures spinal cord stimulation systems used to help relieve pain in patients with chronic, difficult-to-manage pain affecting the trunk or limbs.
FDA materials describe the Senza, Senza II, and Senza Omnia systems as implanted, rechargeable spinal cord stimulation devices that deliver electrical impulses for pain control.

Nevro’s spinal cord stimulator systems include:
Medical records may also refer to Nevro therapy as HF10 or HFX. FDA approval materials state that the Senza platform, including Senza, Senza II, and Senza Omnia, can be programmed to include a 10 kHz frequency, which is central to Nevro’s high-frequency stimulation approach.
For spinal cord stimulator patients trying to identify the exact system implanted, the most useful records are usually the implant card, operative report, programming records, and later follow-up notes.
Those materials may list the product family, implanted components, and therapy terminology used during treatment.
That level of product identification matters because different spinal cord stimulator manufacturers use different naming conventions, and the exact model can affect how lawyers evaluate allegations involving device migration, malfunction, worsening symptoms, or insufficient pain relief.
Accurate device identification is often one of the first steps in a claim review.
For spinal cord stimulator patients who continued treatment after implantation, those records can help show which Nevro system was used, how it was programmed, and whether later care was related to loss of benefit, migration, revision surgery, or other reported complications.
Yes.
Nevro has been named in spinal cord stimulator lawsuits.
Nevro appears in individual filed cases and developing claims, not in a widely recognized Nevro-specific mass tort or consolidated MDL.
Recent public reporting on proposed spinal cord stimulator MDL proceedings focused on other manufacturers, particularly Abbott and Boston Scientific.
Like other spinal cord stimulator cases, the allegations generally involve claims that a device malfunctioned, provided ineffective pain relief or led to worsening chronic pain, migrated, or led to additional surgery or other complications, such as nerve damage, after implantation.
Those allegations remain allegations unless proven in court or resolved through settlement.
You may have a potential claim if you were implanted with a Nevro spinal cord stimulator and later experienced a serious device-related complication.
In many spinal cord stimulator cases, the core issue is whether the implanted system allegedly caused harm beyond the patient’s underlying condition, including malfunction, lead migration, worsening pain, shocking sensations, infection, nerve injury, or the need for revision or explant surgery.
Some patients report chronic nerve pain, neck pain, leg pain, or other symptoms that allegedly developed or intensified after implantation.

Others undergo spinal surgery or additional corrective treatment after device failures or loss of therapeutic benefit.
A claim may also involve allegations of spinal cord compression, spinal cord injuries, irritation near the spinal nerve root, or complications tied to scar tissue formation around implanted components.
Qualification depends on the specific device, the timing of symptoms, the medical records, and the extent of the harm.
Patients who suffered severe injuries or severe complications after receiving one of these modern spinal cord stimulators may have grounds to seek a legal review.
Evidence is critical in claims involving implanted pain devices because the case usually depends on what was implanted, how it performed over time, and what medical treatment followed.
In Nevro spinal cord stimulator cases, the most important records often begin with the operative report from the implantation procedure and the documents created during follow-up care.
Those materials can help establish whether the patient received a Senza, Senza II, or Senza Omnia system, which may matter when evaluating the claim.
Product identification cards, implant stickers, and records listing model and serial numbers are often especially useful because medical device companies may market related systems under different names or configurations.
If the patient later required revision or removal, those surgical records may help document lead migration, device failures, charging problems, or other issues linked to the system.
Imaging may also matter where it shows hardware movement, placement problems, or other abnormalities after implantation.
Programming history and charging-related records can help show whether the device delivered electrical pulses consistently or whether repeated efforts failed to alleviate chronic pain.
It is also important to preserve documentation of symptoms before and after implantation, including reports of physical pain, chronic nerve pain, neck pain, leg pain, or reduced function.

Evidence in these cases may include:
Damages in defective medical device cases are tied to the actual losses the patient suffered after implantation.
In Nevro claims, that may include past and future medical expenses, especially when the patient required revision procedures, explant surgery, or additional spinal surgery because the spinal cord stimulator developed problems after use.
Some patients also claim lost income when severe complications or chronic symptoms keep them from working.
Non-economic damages may include physical pain, reduced quality of life, and other losses associated with long-term disability or persistent limitations.
In more serious cases, a patient may allege ongoing nerve pain, spinal cord injuries, or lasting complications that continue long after the original procedure.
The value of a case depends on the facts, including the device model, the seriousness of the injury, the number of additional procedures, and the long-term impact on the patient’s daily life.
No result is guaranteed, and prior spinal cord stimulator verdicts do not determine the value of any future claim. Each case must be evaluated on its own records and circumstances.

Potential damages may include:
TorHoerman Law is reviewing claims from people who received Nevro spinal cord stimulators and later experienced major complications, device failure, or revision or removal surgery.
These claims may involve allegations that a device intended to alleviate chronic pain instead led to additional medical treatment, persistent symptoms, or other serious harm.
Our firm is investigating spinal cord stimulator risks by reviewing implant records, surgical records, programming history, imaging, and other medical documentation.
That review may help determine whether the available evidence supports a claim against one of the medical device manufacturers involved in this litigation.
We understand that patients may be dealing with severe complications, repeated procedures, and uncertainty about what happened after implantation.

If you believe a Nevro spinal cord stimulator caused you harm, contact TorHoerman Law for a free case review.
You can also use the chatbot on this page to see if you qualify today.
The Nevro models most likely to be relevant on this page are the Senza, Senza II, and Senza Omnia systems.
FDA approval materials identify those product families as part of Nevro’s spinal cord stimulation platform, and some patients may also recognize Nevro’s therapy branding as HF10 or HFX in their paperwork or follow-up records.
That said, eligibility does not depend on the brand name alone.
It usually depends on the exact implanted system, the component involved, the timing of the symptoms, and what the operative report, implant card, and medical records show.
Public reporting and FDA adverse-event records reflect several recurring problem themes involving Nevro spinal cord stimulators.
These include lead migration, loss of pain relief or inadequate pain relief, unwanted or painful stimulation, charging problems, infection, nerve-related injury reports, and revision or explant surgery.
For example, MAUDE reports involving Nevro systems describe revision surgery after lead migration, painful shocking sensations, infection, charging problems, and inadequate pain relief.
Those reports do not prove causation in any individual case, but they do show the kinds of complications that have been publicly reported in connection with these devices.
Possibly, yes.
Revision or explant surgery is one of the clearest facts that may support a claim because it can help show that the patient experienced a significant device-related problem after implantation.
That is especially true when the records also document malfunction, migration, persistent pain, failed therapy, infection, or another serious complication.
The case still depends on the medical records, the identified device, and the surrounding facts tying the complication to the implanted Nevro system.
The most useful sources are usually the implant card, operative records, billing records, and follow-up treatment notes.
Those records may identify the device as Senza, Senza II, Senza Omnia, or refer to the therapy as HF10 or HFX.
In many cases, the model name and device details also appear in programming records or product labeling kept in the chart.
That is why product identification is one of the first steps in evaluating whether a claim may involve a Nevro device family.
No.
An adverse event report or a known complication pattern does not automatically create a legal claim.
MAUDE reports are public safety reports and may include allegations or limited preliminary information, not final findings that a device defect caused a specific injury.
A report like that may still become important evidence when it is combined with proof of implantation, malfunction, injury, and resulting medical treatment.
In other words, the report can support the factual picture, but the strength of any lawsuit still depends on the patient’s own records and circumstances.
Owner & Attorney - TorHoerman Law
Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.
Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.
In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.
In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.
In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.
In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.
Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?